Comparison of the effectiveness of family-centered schema therapy, with and without supportive therapy in reducing the symptoms of patients with borderline personality disorder
Effectiveness of supportive schema therapy
DOI:
https://doi.org/10.22122/cdj.v10i4.713Keywords:
Borderline Personality Disorder, Supportive Therapy, Family-Oriented Schema TherapyAbstract
BACKGROUND: Based on the increasing spread of chronic diseases and their destructive role, a borderline personality disorder is the most common personality disorder in the group of chronic mental diseases. This research aims to compare the effectiveness of family-centered schema therapy, with and without supportive therapy. It was done to reduce the symptoms of patients with borderline personality disorder.
METHODS: This semi-experimental research was conducted with a pre-test/post-test design. 30 people were selected by census method based on the research inclusion criteria from among all patients with a definite diagnosis of borderline personality disorder at Quds Hospital in Sanandaj, Kurdistan, Iran, in the spring of 2021. They were randomly divided into intervention and control groups, and the intervention group received 12 hours of family-oriented intervention and supportive therapy in a group manner in 8 sessions. The data collected through the Borderline Personality Disorder Severity Index (BPDSI) were analyzed by comparing the amount of borderline personality disorder in the research units before and after the intervention using SPSS statistical software.
RESULTS: The average symptoms of borderline personality disorder in supportive therapy and family-centered schema therapy were equal to 13.64 and 11.00, respectively, before the group intervention and 11.24 and 7.92, after the intervention.
CONCLUSION: The combined treatment of family-centered schema therapy with therapeutic support has caused more reduction in the symptoms of borderline personality disorder than the family-centered therapy without therapeutic support; therefore, it is suggested that the combined mode of family-centered schema therapy and therapeutic support should be prioritized in therapeutic interventions.
References
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). Arlington, VA: APA; 2013
Austin MA, Riniolo TC, Porges SW. Borderline personality disorder and emotion regulation: insights from the Polyvagal Theory. Brain Cogn. 2007; 65(1): 69-76.
Martin-Blanco A, Soler J, Villalta L, Feliu-Soler A, Elices M, Perez V, et al. Exploring the interaction between childhood maltreatment and temperamental traits on the severity of borderline personality disorder. Compr Psychiatry. 2014; 55(2): 311-8.
Beck AT, Freeman A, Davis DD. Cognitive Therapy of personality disorders. Trans. Karbalaei D, Meigouni M, Foroughi AA. Tehran, Iran: Arjmand Publications; 2015.
Feist J, Feist G. Theories of personality. Trans. Seyed Mohammadi Y. Tehran, Iran: Ravan Publications; 2017.
Gratz KL, Latzman RD, Tull MT, Reynolds EK, Lejuez CW. Exploring the association between emotional abuse and childhood borderline personality features: the moderating role of personality traits. Behav Ther. 2011; 42(3): 493-508.
Zamani M, Sotodeh Asl N, Makvand Hoseini S, Sabahi P. The effectiveness of schema therapy on the quality of life of adolescent girls with borderline personality disorder. Journal of Applied Family Therapy. 2021; 2(3): 274-55.
Nadort M, Arntz A, Smit JH, Giesen-Bloo J, Eikelenboom M, Spinhoven P, et al. Implementation of outpatient schema therapy for borderline personality disorder: study design. BMC Psychiatry. 2009; 9: 64.
Vakili J, Kimiaee SA, Salehi F. The effectiveness of dialectical behavior therapy on borderline personality disorder symptoms of prisoners. Journal of Clinical Psychology. 2016; 8(3): 97-106.
Jovev M, Chanen A, Green M, Cotton S, Proffitt T, Coltheart M, et al. Emotional sensitivity in youth with borderline personality pathology. Psychiatry Res. 2011; 187(1-2): 234-40.
Yarmohammadi Asl M. Investigating the effectiveness of schema therapy on the improvement of recurrent basic family-centered schema therapy disorder [PhD Thesis]. Tehran, Iran: Allameh Tabataba'i University; 2007.
Bidari F, Hajializadeh K. Effectiveness of schema therapy on cognitive strategies of emotion, distress bearing and alexithymia in the patients suffering from borderline personality disorder. Psychological Studies. 2019; 15(2): 165-80.
Pompili M, Girardi P, Ruberto A, Tatarelli R. Suicide in borderline personality disorder: a meta-analysis. Nord J Psychiatry. 2005; 59(5): 319-24.
Stiglmayr CE, Grathwol T, Linehan MM, Ihorst G, Fahrenberg J, Bohus M. Aversive tension in patients with borderline personality disorder: A computer-based controlled field study. Acta Psychiatr Scand. 2005; 111(5): 372-9.
Lieb K, Zanarini MC, Schmahl C, Linehan MM, Bohus M. Borderline personality disorder. Lancet. 2004; 364(9432): 453-61.
Azad Yekta M, Mohammadian M. Comparing the effectiveness of cognitive-behavioral therapy and psychodrama in depressed women [PhD Thesis]. Tehran, Iran: Science and Research Branch, Islamic Azad University; 2018.
Sahebi Ali. Supportive psychotherapy. Psychotherapical Novelties 2008; 3(9-10): 45-71.
Arntz A, Appels C, Sieswerda S. Hypervigilance in borderline disorder: A test with the emotional Stroop paradigm. J Pers Disord. 2000; 14(4): 366-73.
Salavati M, Yeke Yazdandoost R. Schema therapy: Clinician guide for clinical psychologists. Tehran, Iran: Danjeh Publications; 2015.
Maffei C, Fossati A, Agostoni I, Barraco A, Bagnato M, Deborah D, et al. Interrater reliability and internal consistency of the structured clinical interview for DSM-IV axis II personality disorders (SCID-II), version 2.0. J Pers Disord. 1997; 11(3): 279-84.
Farrell JM, Shaw IA, Webber MA. A schema-
focused approach to group psychotherapy for outpatients with borderline personality disorder: A randomized controlled trial. J Behav Ther Exp Psychiatry. 2009; 40(2): 317-28.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Chronic Diseases Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
